NCT02909400View on ClinicalTrials.gov

The KHENERGY Study

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Mitochondrial DiseasesMitochondrial MyopathiesMitochondrial EncephalomyopathiesMELASMIDD

Interventions

DRUG

KH176

DRUG

placebo

Trial Locations (1)

Unknown

Radboud University Medical Center, Nijmegen

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Radboud University Medical Center

OTHER

lead

Khondrion BV

INDUSTRY